首页 > 资讯
Treasure Global Inc Announces Termination of its At-The-Market Offering Program
2024-10-02 资讯 Treasure Global Inc.NEW YORK and KUALA LUMPUR, Malaysia, Oct. 01, 2024 (GLOBE NEWSWIRE) - Treasure Global Inc (NASDAQ: TGL) (“Treasure Global” or the “Company”), a leading technology solutions provider, is pleased to announce that it has completed its previously disclosed at-the-market equity offering program (“ATM Offering”) launched on March 22, 2024, and the termination of the same with H.C. Wainwright & Co., LLC, as sales agent on September 25, 2024.
The ATM Offering was initiated to offer common shares totaling US$2,990,900 from time to time, and as of the termination date, the Company has sold 1,678,307 of its common shares and raised the maximum total gross proceeds of US$2,990,162.32 before deducting commissions and offering expenses.
The net proceeds from the ATM Offering have been used to support Treasure Global’s continued growth and corporate initiatives, which encompass new business ventures and investments.
This press release does not constitute an offer to sell or the solicitation of an offer to buy securities, nor will there be any sale of the securities in any province, state, or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to the registration or qualification under the securities laws of any such province, state, or jurisdiction.
About Treasure Global Inc:
Treasure Global is a leading Malaysian solutions provider developing innovative technology platforms. Treasure Global has developed the ZCITY Super App, a unique digital ecosystem that transforms and simplifies the e-payment experience for consumers, while simultaneously allowing them to earn rewards. As of August 9, 2024, ZCITY Super App boasts over 2.7 million registered users.
For more information, please visit https://treasureglobal.co.
Cautionary Note Regarding Forward-Looking Statements
This press release contains forward-looking statements that are subject to various risks and uncertainties. Such statements include statements regarding the Company’s ability to grow its business and other statements that are not historical facts, including statements which may be accompanied by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential” or similar words. Actual results could differ materially from those described in these forward-looking statements due to certain factors, including without limitation, the Company’s ability to achieve profitable operations, customer acceptance of new products, the effects of the spread of the coronavirus (COVID-19) and future measures taken by authorities in the countries wherein the Company has supply chain partners, the demand for the Company’s products and the Company’s customers’ economic condition, the impact of competitive products and pricing, successfully managing and, general economic conditions and other risk factors detailed in the Company’s filings with the United States Securities and Exchange Commission. The forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake any responsibility to update the forward-looking statements in this release, except in accordance with applicable law.
For further information, please contact:
Investor and Media Contact
ir_us@treasuregroup.co
- 搜索
-
- 04-11中医药专家于晓津携御君方专家团队出席2025年动脉粥样硬化健康论坛,以临床实证共话中医药科学价值
- 04-11易思脑与汇聚英才成功举行神经回馈训练国际认证助学中心挂牌仪式
- 04-11福城焕新颜 古韵谱华章——金融活水润泽郴州乡村振兴新图景
- 04-11加密货币交易量攀新高 香港券商转型交易量突破百亿居龙头
- 04-11保研录战略收购清华系创业团队“保研印象”,加速清北资源整合与技术创新
- 04-11杜丁副主任医师携御君方全国专家团队亮相2025年动脉粥样硬化健康论坛
- 04-11ProstaVive Reviews (BREAKING REPORT): Must-Read Warnings, Ingredients, Benefits & Real Results U
- 04-11ProstaVive: We Tested It for 90 Days—Our Full Month-by-Month Review and the Shocking Truth About Lon
- 04-11AquaSculpt Reviews (BREAKING): 27,000 CONSUMERS Tracked Over 90 Days—We Finally Have the Answer
- 04-11Bioventra Inc. Reports Surge in Sales of Flagship Wellness Products Mitolyn® and PrimeBiome® in Q1 2